Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND4 pseudogene 32 (MTND4P32) is a putative human pseudogene related in sequence to the mitochondrial gene MT-ND4, which encodes a core subunit of mitochondrial complex I (NADH:ubiquinone oxidoreductase). Unlike the functional MT-ND4 gene, pseudogenes such as MTND4P32 are traditionally considered non-functional genomic elements that no longer produce functional proteins. Some pseudogenes can be transcribed into non-coding RNA and, in certain cases, act as molecular regulators (for example, as miRNA sponges), but there is no direct evidence that MTND4P32 plays a functional or disease-related biological role. Important note: This entry should not be conflated with the functional mitochondrial gene MT-ND4, which is a core enzyme subunit involved in electron transport, and is implicated in various diseases including Leber’s hereditary optic neuropathy and others. MTND4P32, as a pseudogene, is not therapeutically actionable, does not encode a protein, and is not a recognized drug target.
None (not a target for drugs)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND4 pseudogene 32 (MTND4P32).